SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-001167
Filing Date
2024-01-04
Accepted
2024-01-04 08:56:29
Documents
1
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm241766-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm241766-4_4seq1.xml 4 4234
  Complete submission text file 0001104659-24-001167.txt   5979
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Issuer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VACCITECH PLC, UNIT 6-10 ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address
Pelletier Nadege (Reporting) CIK: 0001965689 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40367 | Film No.: 24509871